A 3-year-old spayed female Ragdoll presents for chronic i...

Thank you for presenting this complex case, it certainly sounds like a puzzle. A 3-year-old Ragdoll with chronic GI signs, weight loss, a palpable abdominal mass, thickened loops, and regional lymphadenopathy on ultrasound immediately raises significant concerns, primarily for gastrointestinal neoplasia or severe inflammatory bowel disease (IBD). The good appetite despite weight loss is a key piece of information, often pointing towards malabsorption or excessive caloric expenditure rather than anorexia.

My approach would be methodical, focusing on obtaining a definitive diagnosis while considering the cat's overall health and owner's resources.

Here's how I would recommend proceeding:

1. Initial Baseline Diagnostics & Infectious Disease Screen

Before considering invasive procedures, we need a comprehensive systemic overview:

* Complete Blood Count (CBC): To assess for anemia (anemia of chronic disease, GI blood loss), leukocytosis (inflammation, stress), or leukopenia.
* Serum Biochemistry Panel: To evaluate renal and hepatic function, electrolytes, glucose, albumin, and globulins. Elevated globulins with a low albumin:globulin ratio could raise suspicion for FIP or chronic inflammation/neoplasia.
* Urinalysis (UA): To assess renal concentrating ability, rule out proteinuria, and screen for urinary tract infection.
* Fecal Parasite Exam (Float & Giardia ELISA): To rule out common parasitic causes of chronic GI signs, although less likely to cause a palpable mass.
* Feline Pancreatic Lipase Immunoreactivity (fPLI): To screen for concurrent pancreatitis, which frequently co-occurs with IBD and cholangitis in cats (triaditis).
* Serum Cobalamin (B12) and Folate: These are crucial in chronic GI disease. Low cobalamin suggests ileal malabsorption or bacterial overgrowth, while low folate can indicate proximal small intestinal disease.
* Feline Infectious Peritonitis (FIP) Workup: Given the age and clinical signs (weight loss, GI involvement, lymphadenopathy), FIP is a significant differential, especially in a young cat.
* Alpha-1 Acid Glycoprotein (AGP): An acute-phase protein that is often markedly elevated in FIP.
* Albumin:Globulin Ratio: A ratio <0.8 is highly suspicious for FIP. While not diagnostic on its own, combined with other findings, it adds weight.
Note: While FIP serology (antibody titers) can indicate exposure, it does not confirm active disease and is not recommended as a primary diagnostic tool for FIP.*

2. Detailed Review of Abdominal Ultrasound

I would want to personally review the full ultrasound images or clips, or at a minimum, a very detailed report from a board-certified radiologist. Key details I would be looking for include:

* Intestinal Wall Layering: Is the normal five-layer architecture preserved or effaced? Effacement is highly suggestive of infiltrative disease (lymphoma, severe IBD).
* Wall Thickness Measurements: Which specific segments are thickened and to what extent? (Normal feline duodenum < 2.7 mm, jejunum < 2.3 mm).
* Character of the Mass: Is it truly within the intestinal wall, or is it extramural (e.g., mesenteric lymph node, pancreatic mass)? What is its size, shape, echogenicity, and vascularity?
* Lymph Node Appearance: Size, shape (round vs. oval), internal architecture (loss of normal corticomedullary distinction can suggest neoplasia).
* Mesenteric Fat: Any changes suggestive of steatitis?
* Free Fluid: Presence, amount, and character (anechoic, echogenic).
* Other Organs: Any concurrent changes in the liver, spleen, kidneys, or pancreas?

3. Definitive Diagnosis: Biopsy Strategy

This is the critical step to differentiate between IBD, lymphoma, or other neoplastic processes. Given the palpable mass, thickened loops, and lymphadenopathy, my preference would be for surgical exploration with full-thickness biopsies.

* Surgical Biopsies (Laparotomy):
* Advantages: Allows for visualization and palpation of the entire abdominal cavity, sampling of multiple affected bowel segments (duodenum, jejunum, ileum, stomach if indicated), collection of full-thickness biopsies from the mass and thickened loops, and excisional biopsy of enlarged lymph nodes. Full-thickness biopsies provide the most comprehensive tissue assessment, which is crucial for differentiating infiltrative diseases like IBD and small cell lymphoma, which can be difficult with superficial samples. If the mass is focal and resectable, it could be removed entirely.
* Disadvantages: More invasive, higher cost, longer recovery.
* Protocol: Biopsies should be taken from all grossly abnormal areas, and often from macroscopically normal areas as well (e.g., ileum is crucial for feline GI lymphoma diagnosis). All biopsied tissue should be submitted for histopathology.
* Ancillary Tests on Biopsy: Request immunohistochemistry (IHC) for CD3 and CD20 (T-cell and B-cell markers) if histopathology is equivocal between severe IBD and small cell lymphoma. PARR (PCR for antigen receptor rearrangements) can also be performed on tissue to assess for clonality, which supports a diagnosis of lymphoma.

* Alternative (if surgery is declined or high risk): Endoscopy with Biopsies + Ultrasound-Guided FNA:
* Advantages: Less invasive, faster recovery.
* Disadvantages: Endoscopic biopsies are typically mucosal and submucosal only, which can be insufficient to diagnose transmural lymphoma or severe IBD. The palpable mass might not be accessible endoscopically.
* Protocol: Multiple biopsies (at least 5-7 per site) should be taken from the duodenum, ileum (if accessible), and stomach. Additionally, an ultrasound-guided fine needle aspirate (FNA) of the largest or most abnormal regional lymph node and/or the palpable mass could be pursued.
* FNA Limitations: While FNA can sometimes yield a diagnosis of lymphoma (especially large cell), it is often non-diagnostic for infiltrative bowel disease due to exfoliation issues and sampling error. A negative FNA does not rule out lymphoma. Cytology of lymph nodes can help differentiate reactive hyperplasia from lymphoma, but histopathology is often needed for definitive confirmation.

4. Patient Stabilization

Regardless of the diagnostic path, ensure the cat is adequately supported:

* Fluid Therapy: If dehydrated or showing signs of hypovolemia.
* Antiemetics: Maropitant (1 mg/kg PO/SQ q24h) can help control vomiting and provide some visceral analgesia.
* Appetite Stimulants: If appetite wanes during the workup (e.g., mirtazapine 1.88 mg PO q48-72h for cats).
* Cobalamin Supplementation: If levels are low, start supplementation: 250 mcg SQ weekly for 6 weeks, then monthly.

Given the clinical picture, I have high confidence that surgical biopsies will provide the most definitive diagnosis. This will allow us to differentiate between IBD, small cell lymphoma (which often has a better prognosis than large cell), or other less common pathologies, and guide appropriate treatment. I would strongly recommend against empirical steroid therapy before obtaining a diagnosis, as it can mask disease and complicate histopathological interpretation.

Please let me know the results of your initial bloodwork and the detailed ultrasound findings. I'm happy to review them and discuss the biopsy options further.